AMPLARI

Serial Number 85619263
606

Registration Progress

Application Filed
May 8, 2012
Under Examination
Jun 4, 2013
Approved for Publication
Apr 9, 2013
Published for Opposition
Apr 9, 2013
Registered

Trademark Image

AMPLARI

Basic Information

Serial Number
85619263
Filing Date
May 8, 2012
Published for Opposition
April 9, 2013
Abandonment Date
January 4, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 4, 2016
Classes
005

Rights Holder

ALKERMES PHARMA IRELAND LIMITED

03
Address
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4
IE

Ownership History

Alkermes, Inc.

Original Applicant
03
Waltham, MA

ALKERMES PHARMA IRELAND LIMITED

New Owner Before Publication #1
03
DUBLIN 4 IE

ALKERMES PHARMA IRELAND LIMITED

Owner at Publication
03
DUBLIN 4 IE

Legal Representation

Attorney
Norman J. Rich

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description Documents
Jan 4, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 4, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
May 2, 2015 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
May 1, 2015 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 27, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 7, 2015 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 28, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 28, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 15, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 14, 2014 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 9, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 9, 2014 EXT3 S SOU EXTENSION 3 FILED Loading...
May 2, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 1, 2014 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 30, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 13, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 13, 2014 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 5, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 1, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 1, 2013 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 1, 2013 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 4, 2013 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 9, 2013 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 9, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 20, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 6, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Mar 4, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 28, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 28, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 24, 2013 ALIE A ASSIGNED TO LIE Loading...
Feb 21, 2013 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 5, 2012 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 5, 2012 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 5, 2012 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 22, 2012 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 15, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 11, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005